C12N 2501/145
Thrombopoietin [tpo]
Official title: Thrombopoietin [TPO]
C12N2501/145 (Thrombopoietin [tpo]) appears on 228 US grants and 575 published applications in this corpus.
Search patents in C12N- Granted patents
- 228
- Published applications
- 575
- Assignees
- 302
- Inventors
- 989
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 7 |
| 2003 | 3 | 3 |
| 2004 | 2 | 7 |
| 2005 | 3 | 23 |
| 2006 | 1 | 12 |
| 2007 | 3 | 8 |
| 2008 | 8 | 16 |
| 2009 | 4 | 9 |
| 2010 | 7 | 19 |
| 2011 | 3 | 15 |
| 2012 | 7 | 15 |
| 2013 | 11 | 18 |
| 2014 | 9 | 19 |
| 2015 | 15 | 21 |
| 2016 | 14 | 26 |
| 2017 | 10 | 15 |
| 2018 | 12 | 36 |
| 2019 | 8 | 28 |
| 2020 | 15 | 38 |
| 2021 | 9 | 40 |
| 2022 | 10 | 37 |
| 2023 | 12 | 38 |
| 2024 | 20 | 41 |
| 2025 | 17 | 43 |
| 2026 | 13 | 40 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of culturing quiescent hematopoietic stem cells and treatment methods6 Oct 2026US 12,753,389 B2Icahn School of Medicine at Mount Sinai
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Compositions and methods for providing hematopoietic function without HLA matching22 Sep 2026US 12,741,001 B2Fred Hutchinson Cancer Center
- Methods for directed differentiation of pluripotent stem cells to HLA homozygous immune cells25 Aug 2026US 12,716,058 B2FUJIFILM Cellular Dynamics, Inc.
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Method for modulating the differentiation and functions of human dendritic cells1 Oct 2026US 2026/0297524 A1Centre National De La Recherche Scientifique
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells1 Oct 2026US 2026/0297528 A1Arizona Board of Regents on behalf of Arizona State University
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Media and methods for differentiating t cells from hematopoietic stem cells17 Sep 2026US 2026/0272984 A1The Regents of the University of California
Most cited
By later US patents
- Medium for growing human embryonic stem cells127US 7,297,539 B2Geron Corporation · 2007
- Culture system for rapid expansion of human embryonic stem cells97US 7,410,798 B2Geron Corporation · 2008
- Production of megakaryocytes by the use of human mesenchymal stem cells87US 6,225,119 B1Osiris Therapeutics, Inc. · 2001
- Mammalian myeloid progenitor cell subsets78US 6,465,247 B1The Board of Trustees of the Leland Stanford Junior University · 2002
- Method of producing undifferentiated hemopoietic stem cells using a stationary phase plug-flow bioreactor69US 6,911,201 B1Technion Research & Development Foundation Limited · 2005